1. Home
  2. FOSL vs INDP Comparison

FOSL vs INDP Comparison

Compare FOSL & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

SELL

Current Price

$7.16

Market Cap

418.7M

ML Signal

SELL

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

SELL

Current Price

$2.43

Market Cap

438.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FOSL
INDP
Founded
1984
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
418.7M
438.4M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
FOSL
INDP
Price
$7.16
$2.43
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $9.25
N/A
AVG Volume (30 Days)
★ 733.7K
657.6K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 25.26
N/A
EPS
N/A
★ N/A
Revenue
★ $1,004,406,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.39
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.70
$0.92
52 Week High
$7.33
$5.96

Technical Indicators

Market Signals
Indicator
FOSL
INDP
Relative Strength Index (RSI) 69.18 48.43
Support Level $3.74 $2.30
Resistance Level $7.33 $2.96
Average True Range (ATR) 0.38 0.36
MACD 0.05 -0.12
Stochastic Oscillator 88.98 18.63

Price Performance

Historical Comparison
FOSL
INDP

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: